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Males,	mixed	cancer	-	Nwosu	2016[22]	 306.6	 26.1	 354	 371.9	 43.2	 30.8	 7.2	 0.19	 -0.65	
Females,	mixed	cancer	-	Nwosu	2016[22]	 372.2	 29.1	 372	 298.6	 49.0	 34.4	 7.7	 0.01	 -0.69	
Males,	White,	Lung	cancer	stage	IIIB,	-	Toso	2000[20]	 302.0	 25.0	 354	 371.9	 43.2	 30.8	 7.2	 0.08	 -0.81	
Males,	White,	Lung	cancer	stage	IV,	-	Toso	2000[20]	 314.0	 24.0	 354	 371.9	 43.2	 30.8	 7.2	 0.36	 -0.94	
Females	with	breast	cancer	-	Malecka-Massalska	2012[30]	2013[31]	 377.54	 53.58	 372	 298.6	 49.0	 34.4	 7.7	 0.12	 2.49	
Males	with	head	and	neck	cancer-		Melecka-Massalska		2013[33]	 342.54	 27.62	 354	 371.9	 43.2	 30.8	 7.2	 1.02	 -0.44	
Males	with	lung	cancer	locally	advanced	and	disseminated	-	Toso	2003[18]	 317	 26.0	 354	 371.9	 43.2	 30.8	 7.2	 0.43	 -0.67	
Males	with	lung	cancer	in	remission	-	Toso	2003[18]	 287	 25.0	 354	 371.9	 43.2	 30.8	 7.2	 -0.27	 -0.81	
Males	with	head	and	neck	cancer	-	Melecka-Massalska		2013[33]	 327.01	 28.04	 354	 371.9	 43.2	 30.8	 7.2	 0.66	 -0.38	
Females	(mixed	race)	gynaecological	cancer	-	Cardoso	2017[34]	 349.8	 34.4	 372	 298.6	 49.0	 34.4	 7.7	 -0.45	 0.00	
*The	Piccoli	et	al	1995[24]	reference	population	data	was	used	for	all	studies	included	in	this	analysis.	BIVA	software	equations	are	included	in	517	
the	appendix.	518	
	519	
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Figure	1:	The	RXc	graph	with	95%,	75%	and	50%	tolerance	ellipses.	Reproduced	and	521	
modified	with	permission.[51]	522	
	523	
Figure	2:	The	BIVA	z-score	graph:	data	drawn	from	the	literature	and	plotted	on	the	RXc	z-524	
score	graph	after	transformation	of	the	impedance	measurements	from	several	disease	525	
groups	into	bivariate	z-scores	(with	respect	to	their	reference	population).	Modified	with	526	
permission.[23]	527	
Solid	and	open	circles	represent	male	and	female,	respectively.	A	forward	or	backward	528	
displacement	of	vectors	parallel	to	the	major	axis	of	ellipses	was	associated	with	529	
dehydration	or	fluid	overloading,	respectively,	reaching	extremes	out	of	the	poles.	Single	530	
score	vectors	are	from	athletes,[52]	obese	subjects	of	class	I	to	III[53]	or	patients	with	531	
chronic	renal	failure	in	conservative	treatment,	nephrotic	syndrome	(oedema),	lung	532	
cancer,[20]	acquired	immunodeficiency	syndrome	in	stages	WR	3	to	5	or	WR	6,[54]	and	533	
anorexia	nervosa.[55]	Repeated	score	vectors	are	from	climbers	before	and	after	high	534	
altitude	dehydration,[56]	Haemodialysis	patients,	either	lean[57]	or	obese,[53]	before	and	535	
after	fluid	removal	with	a	dialysis	session,	and	dehydrated	patients	with	cholera	before	and	536	
after	fluid	infusion.[12]	Vectors	above	or	below	the	major	axis	(meaning	upper	left	or	lower	537	
right	half	of	ellipses)	were	associated	with	more	or	less	cell	mass	in	soft	tissues,	respectively,	538	
with	extremes	along	the	minor	axis.	Abbreviations:	CRF	=	chronic	renal	failure;	HD=	539	
haemodialysis;	HDo=	obese	haemodialysis	patients;	HIV=	human	immunodeficiency	virus	540	
stages	1-6;	Ob/1-3=	obese	subjects	of	classes	I	to	III;	WR=	Walter	Reed	stages	1-6.		541	
Reproduced	with	permission.[23]	542	
		 28	
Figure	3:	Overall	selection	process	for	clinical	studies	included	in	the	BIVA	Z	score	analysis	543	
	544	
Figure	4:	RXc	z-score	graph	analysis	of	bioelectrical	impedance	vector	analysis	(BIVA)	data	545	
from	studies	of	patients	with	cancer.	546	
Data	drawn	from	the	literature	and	plotted	on	the	RXc-score	graph	after	transformation	of	547	
impedance	measurements	from	several	disease	groups	into	bivariate	Z	scores	(with	respect	548	
to	the	Piccoli	1995	reference	population[24]).	Further	details	of	the	equations	used	for	the	549	
analysis	are	available	in	the	appendix.550	
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